In re: Open Medicine Institute, Inc. Andreas M. Kogelnik

CourtUnited States Bankruptcy Appellate Panel for the Ninth Circuit
DecidedMay 26, 2022
DocketNC-21-1233-FBS NC-21-1234-FBS
StatusPublished

This text of In re: Open Medicine Institute, Inc. Andreas M. Kogelnik (In re: Open Medicine Institute, Inc. Andreas M. Kogelnik) is published on Counsel Stack Legal Research, covering United States Bankruptcy Appellate Panel for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re: Open Medicine Institute, Inc. Andreas M. Kogelnik, (bap9 2022).

Opinion

FILED ORDERED PUBLISHED MAY 26 2022

SUSAN M. SPRAUL, CLERK U.S. BKCY. APP. PANEL OF THE NINTH CIRCUIT

UNITED STATES BANKRUPTCY APPELLATE PANEL OF THE NINTH CIRCUIT

In re: BAP No. NC-21-1233-FBS OPEN MEDICINE INSTITUTE, INC., Debtor. Bk. No. 20-51678

SPARK FACTOR DESIGN, INC.; WORKING DIRT R2, LLC, Appellants, v. FRED S. HJELMESET, Chapter 7 Trustee, Appellee.

In re: BAP No. NC-21-1234-FBS ANDREAS M. KOGELNIK, Debtor. Bk. No. 21-50203

SPARK FACTOR DESIGN, INC.; WORKING DIRT R2, LLC, Appellants, v. OPINION ANDREAS M. KOGELNIK, Appellee.

Appeal from the United States Bankruptcy Court for the Northern District of California Stephen L. Johnson, Bankruptcy Judge, Presiding

APPEARANCES: Gary M. Kaplan of Farella Braun & Martel LLP argued for appellants; Gregg S. Kleiner of Rincon Law, LLP argued for appellee Fred S. Hjelmeset; Matthew G. Kleiner of Gordon Rees Scully Mansukhani, LLP argued for appellee Andreas M. Kogelnik.

Before: FARIS, BRAND, and SPRAKER, Bankruptcy Judges.

Opinion by Judge Faris Concurrence by Judge Spraker

FARIS, Bankruptcy Judge:

INTRODUCTION

This appeal arises out of “business divorce” litigation among Open

Medicine Institute, Inc. (“OMI”), its founder and former principal,

Dr. Andreas M. Kogelnik, and its current principals and creditors, Spark

Factor Design, Inc. (“Spark Factor”) and Working Dirt R2, LLC (“Working

Dirt”). After OMI filed a chapter 71 petition and Dr. Kogelnik filed a

chapter 11 petition, the bankruptcy court approved a settlement between

Dr. Kogelnik and OMI’s chapter 7 trustee, Fred S. Hjelmeset (“Trustee”).

Spark Factor and Working Dirt appeal, arguing that the bankruptcy court

failed to properly evaluate the settlement as a sale of estate assets and erred

in determining that the compromise was fair and equitable.

While the Trustee could have better supported his analysis of the

claims and settlement, the bankruptcy court did not abuse its discretion in

relying on his business judgment. Furthermore, it did not need to treat any

portion of the compromise as a sale or force the Trustee to accept the

appellants’ alternative proposal. We AFFIRM. We publish to clarify that

bankruptcy courts do not always need to examine a compromise as a sale

1 Unless specified otherwise, all chapter and section references are to the Bankruptcy Code, 11 U.S.C. §§ 101-1532, and all “Rule” references are to the Federal Rules of Bankruptcy Procedure. under § 363.

FACTS

A. Prepetition events

In or around 2008, Dr. Kogelnik formed OMI, a medical research

company, and became its CEO and sole shareholder. Appellant Spark

Factor and Valley Community Fund, Inc. (“VCFI”) acquired the majority

stake in OMI in 2019. Spark Factor’s CEO and primary shareholder is

Abraham Farag, and his brother is the CEO, secretary, and treasurer of

VCFI. Mr. Farag’s wife is the managing member of appellant Working Dirt.

Beginning in December 2019, OMI borrowed a total of $2.3 million

from Spark Factor. It also borrowed $2.5 million from Working Dirt.

Dr. Kogelnik personally guaranteed the loans.

In early 2020, Laura Gingher, Spark Factor’s operations manager,

became OMI’s CFO, and later its CEO, secretary, treasurer, and board

member; Mr. Farag became the chairman of OMI’s board. They effectively

took control of OMI’s operations.

In June 2020, Spark Factor acquired additional stock in OMI to

increase its equity share to ninety-three percent. By the petition date,

Dr. Kogelnik owned only a five-percent interest in OMI.

Shortly after Spark Factor acquired its controlling stake in OMI,

Dr. Kogelnik left his positions as CEO and director of OMI. He claimed that

Mr. Farag and Ms. Gingher improperly forced him out; conversely, Spark

Factor and Working Dirt asserted that the board forced him to resign due 3 to his gross mismanagement of OMI, misappropriation of its assets, and

deception of lenders, investors, and others for his personal benefit.

Before Spark Factor and Working Dirt became involved in its

business, OMI executed a lease for real properties in Mountain View,

California. The lease required a security deposit of over $2.3 million. On

September 9, 2020, Ms. Gingher executed an assignment of OMI’s lease to

Spark Factor, which included OMI’s interest in the remaining $1.9 million

security deposit. Spark Factor claimed that the lease was in default and

distressed, but the Trustee contended that Spark Factor extended the lease

and sublet the properties (including to OMI) at a profit.

OMI filed three state court complaints against Dr. Kogelnik and other

entities, including his companies Open Medicine Clinic, Inc. (“OMCI”) and

Basis Diagnostics, Inc. (“Basis”). Essentially, OMI alleged that Dr. Kogelnik

breached his fiduciary duties to OMI and appropriated OMI’s money,

resources, services, and intellectual property to benefit his other

companies. The parties refer to the claims arising from these lawsuits as the

“State Court Litigation Claims.”

B. The bankruptcy petitions

In November 2020, OMI filed a chapter 7 bankruptcy petition. The

Trustee was appointed to administer the estate. Dr. Kogelnik filed a $1.35

million proof of claim based on prepetition loans.

The Trustee asserted that OMI had various litigation claims against

the officers, directors, and insiders of OMI, including Mr. Farag, his wife 4 and brother, Ms. Gingher, Spark Factor, Working Dirt, and VCFI. (The

parties refer to this group as the “Targeted Parties.”2). He claimed that the

Targeted Parties breached their fiduciary duties to OMI by engaging in

conduct that benefitted themselves to the detriment of OMI (the so-called

“BOFD Claims”). He also claimed to own the so-called “Causes of Action”:

“rights of set-off, recoupment rights, offsets, alter ego, veil piercing,

substantive consolidation, successor liability, and other claims” against

unspecified parties. The parties referred to the BOFD Claims and the

Causes of Action together as the “Litigation Claims.”

Meanwhile, Dr. Kogelnik filed his own chapter 11 petition. The

Trustee filed an unliquidated proof of claim asserting that Dr. Kogelnik

may have breached his fiduciary duties to OMI and caused financial injury

to OMI. Additionally, Spark Factor and Working Dirt filed complaints

against Dr. Kogelnik under §§ 523 and 727.

C. The Trustee’s motion to compromise

The Trustee and Dr. Kogelnik eventually agreed to resolve the

disputes between OMI’s estate and Dr. Kogelnik. In September 2021, the

Trustee filed a motion to approve a settlement agreement with

Dr. Kogelnik, Basis, and OMCI (the “Kogelnik Parties”).

In summary, the settlement agreement provided that the Trustee

would: (1) settle the BOFD Claims, the Causes of Action, and the State 2 The record does not make clear whether Dr. Kogelnik and his entities are among the Targeted Parties. However, counsel for the Trustee represented at oral argument that the Targeted Parties do not include Dr. Kogelnik and his entities. 5 Court Litigation Claims that the Trustee held against the Kogelnik Parties;

(2) sell to Basis the estate’s rights and interests in the Litigation Claims

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Van Zandt v. Mbunda (In Re Mbunda)
484 B.R. 344 (Ninth Circuit, 2012)
United States v. Hinkson
585 F.3d 1247 (Ninth Circuit, 2009)
Simantob v. Claims Prosecutor, LLC (In Re Lahijani)
325 B.R. 282 (Ninth Circuit, 2005)
In Re Vazquez
325 B.R. 30 (S.D. Florida, 2005)
Garner v. Shier (In Re Garner)
246 B.R. 617 (Ninth Circuit, 2000)
Burton v. Ulrich (In Re Schmitt)
215 B.R. 417 (Ninth Circuit, 1997)
Suter v. Goedert
396 B.R. 535 (D. Nevada, 2008)
Said Adeli v. Christopher Barclay
834 F.3d 1036 (Ninth Circuit, 2016)
Greif & Co. v. Brian Shapiro
705 F. App'x 600 (Ninth Circuit, 2017)
Fuchs v. Snyder Trust Enterprises
335 Fed. Appx. 669 (Ninth Circuit, 2009)
Groppi v. Barham
157 F. App'x 10 (Ninth Circuit, 2005)
Kallman & Co. LLP v. Gottlieb (In re Lewis)
515 B.R. 591 (Ninth Circuit, 2014)
Van Zandt v. Mbunda (In re Mbunda)
604 F. App'x 552 (Ninth Circuit, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
In re: Open Medicine Institute, Inc. Andreas M. Kogelnik, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-open-medicine-institute-inc-andreas-m-kogelnik-bap9-2022.